{"id":"W3009824331","doi":"10.7573/dic.2019-11-4","title":"Pharmaceutical, clinical, and resistance information on doravirine, a novel non-nucleoside reverse transcriptase inhibitor for the treatment of HIV-1 infection","year":2020,"lang":"en","type":"review","venue":"Drugs in Context","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Regina; McGill University; Jewish General Hospital","funders":"","keywords":"Reverse-transcriptase inhibitor; Lamivudine; Medicine; Regimen; Nucleoside Reverse Transcriptase Inhibitor; Virology; Drug resistance; Nucleoside; Clinical trial; Pharmacology; Human immunodeficiency virus (HIV); Virus; Sida; Internal medicine; Antiretroviral therapy; Viral disease; Biology; Viral load; Genetics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003571836,0.0006913446,0.001316365,0.003034504,0.0002588886,0.0007630308,0.0005327503,0.0007070845,0.006862933],"category_scores_gemma":[0.0006131273,0.0002163591,0.0006725522,0.002851238,0.0002306586,0.0007596749,0.000456929,0.001115753,0.002280723],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003876021,"about_ca_system_score_gemma":0.000963797,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001010876,"about_ca_topic_score_gemma":0.002298295,"domain_scores_codex":[0.9998201,0.00003125993,0.00003259411,0.00002745294,0.00007310278,0.00001560979],"domain_scores_gemma":[0.9997076,0.000155096,0.00005209653,0.000008987873,0.00005674106,0.00001942781],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000624759,0.00005904994,0.00009397761,0.05164053,0.0001490148,0.0001562354,0.00006833138,0.0002745845,0.002421357,0.002729272,0.03051816,0.9118271],"study_design_scores_gemma":[0.00001705093,0.0001146554,0.0008077362,0.01007601,0.0002937805,0.001022646,0.00004170316,0.00006306171,0.0004441804,0.0008401131,0.9862628,0.00001625724],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001714,0.9967989,0.000101208,0.000165155,0.0001719722,0.0000117933,0.0000814196,0.000009174164,0.002489032],"genre_scores_gemma":[0.000489235,0.9984341,0.000146686,0.0001477164,0.00007692201,0.000007162978,0.00006921254,0.000001310765,0.0006276111],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006862933,"threshold_uncertainty_score":0.02295882,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07832152487031797,"score_gpt":0.3881401415408423,"score_spread":0.3098186166705243,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}